CGRP antibodies are coming to Canada and are stirring a lot of interest from the medical community. Patients also have many questions about these new treatments. Migraine Canada has created a handout to provide basic information. Have a look, and if you are a health...
Dear Colleague, Migraine Canada is inviting patients to participate in a survey to produce a patient review in support of erenumab (Aimovig) for CADTH, (Canadian Agency for Drugs and Technologies in Health). Migraine Canada is committed to provide reviews for ALL new...
Dear CHS colleagues, Please find a message from the AHS president, Kathleen Digre, summarizing some aspects of CGRP MAB therapy. Exciting prospects ahead (and lots of forms) — Elizabeth Leroux, MD, FRCPC Clinical Associate Professor, Neurology Headache Leader,...
The Canadian Headache Society is dedicated to the training of Neurology residents in headache. Once again, we assemble a fantastic group of speakers in Montreal to talk about the diagnosis and treatment of headache disorders. Our two guest speakers this year...
The next International Headache Congress will take place in Vancouver, Canada. Join us for four days of conferences and scientific breakthroughs. CGRP antibodies phase-3 trials are underway and some results will be presented at this congress. Be a part of the social...
